Halda Therapeutics Revenue
Biotechnology Research • 
New Haven, Connecticut, United States • 21-50 Employees
Halda Therapeutics revenue & valuation
| Annual revenue | $11,000,000 |
| Revenue per employee | $240,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $35,200,000 |
| Total funding | $177,000,000 |
Key Contacts at Halda Therapeutics
Craig Crews
Founder
Nilesh Zaware
Associate Director Clinical Operations
James J. Mousseau
Director - Chemistry
Mariann Downing
Director Program Management
Sharon Hyzy
Director, Clinical And Research Program Management
Jenn Toomey
Director Of Data Management
David Puleo
Director
Luke Mcmurtray
Director Cmc
Louise Giffin
Associate Director, Biology
Matthew Perry
Director
Company overview
| Headquarters | 115 Munson Street, Suite 101, New Haven, Connecticut 06511, US |
| Phone number | +14752100212 |
| Websites | |
| NAICS | 541714 |
| Employees | 21-50 |
| Socials |
Halda Therapeutics Email Formats
Halda Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@haldathera.com), used 93.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@haldathera.com | 93.3% |
{first initial}.{last name} | j.doe@haldathera.com | 6.7% |
About Halda Therapeutics
Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic disease drivers to target cancer. This powerful technology is designed to overcome the known bypass mechanisms of drug resistance, a common limitation of today’s precision cancer medicines. Using a novel ‘hold and kill’ mechanism, RIPTAC therapeutics target cancer cells selectively by bringing two proteins together in a tightly regulated manner, causing the loss of an essential function for cell survival and subsequent cancer cell death. We have built a pipeline of RIPTAC therapeutics for major cancer types, uniquely addressing the unmet needs of drug resistant cancer patients, and we will continue to invent new medicines using our proprietary platform technology. We are a bold company where collaboration, passion, and creativity thrive, all of which allows us to push the boundaries of drug discovery to identify better solutions. Halda is proud to be a New Haven, CT based biotech, located with headquarters and state-of-the-art labs in Science Park.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Halda Therapeutics has 19 employees across 8 departments.
Departments
Number of employees
Funding Data
Explore Halda Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Halda Therapeutics Tech Stack
Discover the technologies and tools that power Halda Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Analytics
SEO
CDN
Canada
Switzerland
Portugal
Russian Federation
Frequently asked questions
4.8
40,000 users
